- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-Small Cell Lung Cancer in South Africa
Total 1611 results
-
Novartis PharmaceuticalsActive, not recruitingNon-small Cell Lung CancerUnited States, Canada, Italy, Spain, Malaysia, Taiwan, Turkey, Australia, Germany, Netherlands, Singapore, Argentina, Austria, Czechia, Switzerland, United Kingdom, Korea, Republic of, Thailand, France, Japan, Lebanon, Greece, Hong... and more
-
Regeneron PharmaceuticalsRecruitingNon-small Cell Lung CancerKorea, Republic of, United States, Malaysia, Australia, Georgia, Israel, Canada
-
Hoffmann-La RocheCompletedSquamous Non-Small Cell Lung CancerUnited States, Spain, France, Australia, Germany, Taiwan, Canada, Argentina, Belgium, Singapore, Brazil, Netherlands, Israel, Portugal, Russian Federation, Japan, Italy, Chile, Latvia, Peru, Ukraine, Lithuania, Slovakia, Bulgaria, Mexico, Austri...
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerChina, Korea, Republic of, South Africa, Taiwan, Hungary, France, Netherlands, United States, Bulgaria, Slovakia, Canada, Italy, Brazil, Thailand, Romania, Lithuania, Poland, Latvia, Ukraine, Czech Republic
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedLung CancerUnited States, Puerto Rico, South Africa
-
TelikTerminatedNon-small Cell Lung CancerUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States, Australia, Puerto Rico, South Africa
-
AmgenRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Australia, Netherlands, Taiwan, Korea, Republic of, United Kingdom, Spain, Austria, Japan, Switzerland, Sweden, France, Czechia, Italy, Portugal, Hong Kong, Thailand, Singapore, Bulgaria, Turkey, Argentina, Belgium, G... and more
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Hoffmann-La RocheTerminatedNon-Small Cell Lung CancerAustralia
-
Cellectar Biosciences, Inc.CompletedNon Small Cell Lung CancerUnited States, Israel, Canada, Spain, Russian Federation, Serbia, Italy, Poland, Romania, Switzerland, Ukraine, United Kingdom
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedNon-small Cell Lung CancerUnited States, Sweden, Australia, Czech Republic, France, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, Germany, China, Poland, Romania, Denmark, Hong Kong, Canada, Austria, Belgium, Hungary, Israel, Nether... and more
-
Medical University of South CarolinaNovartis PharmaceuticalsCompletedSoft Tissue Sarcoma | Renal Cancer | Non Small Cell Lung Cancer (NSCLC)United States
-
National Cancer Institute (NCI)RecruitingStage IV Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Recurrent Lung Non-Squamous Non-Small Cell CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedALK-positive Non-small Cell Lung CancerUnited States, France, Italy, United Kingdom, Taiwan, Turkey, Belgium, Germany, Canada, Singapore, Spain, Korea, Republic of, Netherlands, Russian Federation, Brazil, Hong Kong, Australia
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerUnited States, Canada
-
Nasser Hanna, M.D.Sanofi; Walther Cancer InstituteCompletedNon-Small Cell Lung CancerUnited States
-
Tragara Pharmaceuticals, Inc.CompletedRecurrent Non Small Cell Lung CancerUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Recurrent Lung Non-Squamous Non-Small Cell CarcinomaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedFirst Line Non-Small Cell Lung CancerSpain, United States, Hungary, Israel, China, Korea, Republic of, Taiwan, Czechia, Russian Federation, Australia, Brazil, Lebanon, Serbia, Thailand, Canada, Slovakia, Ukraine, Bulgaria, Italy, Netherlands, New Zealand, Poland, Belgium, Turk... and more
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaRecruitingMetastatic Non Small Cell Lung CancerBelgium, Australia, United States, Korea, Republic of, Spain, China, France, Germany, Thailand, Brazil, Japan, Hong Kong, Greece, Switzerland, Netherlands, Romania, Hungary, Italy, Chile, Taiwan, Austria, Poland, Canada, Argentina, Turkey
-
University of ChicagoNational Cancer Institute (NCI)Completed
-
University of ChicagoNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
PfizerCompletedALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLCUnited States, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republic of, Spain, Belgium, Switzerland, France, Germany, Hong Kong, Italy
-
Clovis Oncology, Inc.TerminatedLocally Advanced or Metastatic Non Small Cell Lung CancerUnited States, Australia, France, Poland
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Australia, United States, Turkey, Chile, Taiwan, Denmark, France, Spain, Argentina, Italy, Netherlands, Thailand, Korea, Republic of
-
Nasser Hanna, M.D.Bristol-Myers Squibb; Eli Lilly and Company; Walther Cancer InstituteCompletedNon-Small Cell Lung CancerUnited States
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung CancerSpain, Argentina, China, France, Turkey, Brazil, Korea, Republic of, Mexico, Chile, Guatemala, Peru, Thailand, Costa Rica, United Kingdom, New Zealand, Hungary, Latvia, Russian Federation, South Africa, Ukraine, Italy, Greece, Poland
-
Hoosier Cancer Research NetworkEli Lilly and CompanyTerminatedNon-Small Cell Lung CancerUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNonsquamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Chile, China, France, Germany, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, United Kingdom
-
Genentech, Inc.CompletedLung Cancer | Non-small-cell Lung CarcinomaUnited States
-
AstraZenecaParexelActive, not recruitingAdvanced or Metastatic Non-Small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, Romania, Canada, Korea, Republic of, Brazil, Hungary, Japan, China, Taiwan, Hong Kong, United Kingdom, Germany, Poland, Australia, Netherlands, Serbia, India, Argentina, Ireland
-
National Cancer Institute (NCI)RecruitingLung Non-Small Cell Carcinoma | Lung Non-Small Cell Squamous Carcinoma | Lung Non-Squamous Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8United States, Guam
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Mirati Therapeutics Inc.Bristol-Myers SquibbActive, not recruitingMetastatic Non-Squamous Non-Small Cell Lung CancerUnited States, Canada, Belgium, France, Germany, Hungary, Israel, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Australia, Japan, Korea, Republic of, Spain
-
SCRI Development Innovations, LLCBayerCompletedNon-Small Cell Lung CancerUnited States
-
EpimmuneUnknownLung CancerUnited States
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Australia, Japan
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Taiwan, United States, Australia, Israel, Hong Kong, Chile, Korea, Republic of, Canada, Malaysia, Thailand
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Trans Tasman Radiation Oncology GroupCancer Council Queensland; Victorian Cancer CouncilCompleted
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States, Canada
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationSpain, United States, Korea, Republic of, Taiwan, Italy, Australia, France
-
SystImmune Inc.RecruitingBreast Cancer | Small Cell Lung Cancer | Nasopharyngeal Cancer | Esophageal Cancer | NSCLC | Lung Cancer | Non Small Cell Lung Cancer | SCLC | NPCUnited States
-
SCRI Development Innovations, LLCBristol-Myers Squibb; Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
Janssen Research & Development, LLCActive, not recruitingAdvanced or Metastatic Non-small Cell Lung CancerItaly, United States, Germany, Japan, China, Korea, Republic of, Israel, Portugal, Taiwan, Thailand, Malaysia, United Kingdom, Australia, Turkey, Poland, Spain, Brazil, Canada, Argentina, France
-
NRG OncologyNational Cancer Institute (NCI)RecruitingStage III Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Locally Advanced Lung Non-Small Cell CarcinomaUnited States
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedLung CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
Xcovery Holdings, Inc.Active, not recruitingNon-small Cell Lung CancerSpain, United States, China, Korea, Republic of, Hong Kong, United Kingdom, Poland, Israel, Germany, France, Argentina, Australia, Brazil, Canada, Czechia, Italy, Netherlands, Russian Federation, Turkey, Belgium